Evolent Health Inc.

NYSE: EVH · Real-Time Price · USD
8.82
-0.14 (-1.62%)
At close: Aug 14, 2025, 3:59 PM
8.86
0.45%
Pre-market: Aug 15, 2025, 07:19 AM EDT

Evolent Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.55B 1.96B 1.35B 907.96M
Cost of Revenue
2.19B 1.5B 1.04B 657.55M
Gross Profit
367.35M 460.47M 316.58M 250.41M
Operating Income
-40.48M -71.21M 3.64M -42.41M
Interest Income
5.54M 5.26M 1.37M 407K
Pretax Income
-63.04M -202.41M -62.08M -29.8M
Net Income
-61.62M -113.04M -19.16M -30.8M
Selling & General & Admin
263.05M 358.11M 269.27M 219.5M
Research & Development
n/a n/a 27M 26.5M
Other Expenses
144.79M 173.57M 16.67M 46.82M
Operating Expenses
407.84M 531.68M 312.94M 292.82M
Interest Expense
24.72M 54.2M 15.57M 25.43M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
2.6B 2.04B 1.35B 950.37M
Income Tax Expense
-1.41M -89.36M -43.38M 483K
Shares Outstanding (Basic)
114.68M 111.25M 93.7M 86.07M
Shares Outstanding (Diluted)
114.68M 111.25M 93.7M 86.07M
EPS (Basic)
-0.81 -1.28 -0.2 -0.36
EPS (Diluted)
-0.81 -1.28 -0.2 -0.36
EBITDA
84.85M -24.79M 43.75M 55.66M
EBIT
-38.31M -148.2M -46.51M -4.38M
Depreciation & Amortization
123.17M 123.42M 90.25M 60.04M